Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AVADO Presented At ASCO; But After The Fanfare, What Does It Signify?

Jun 09 2008

• By Mary Jo Laffler

Related Content

Progression-Free Survival Must Be Tied To Survival For Oncologic Approval

Mar 20 2006

“Exceptional” Approval Could Replace “Accelerated” For Rare Cancer Drugs

Nov 14 2005

ODAC Split On Avastin Use In First-Line Metastatic Breast Cancer

Dec 10 2007

Progression-Free Survival Represents Clinical Benefit, But How Much? – ODAC

Dec 17 2007

Avastin Growth Cut By Colorectal Cancer Competition, Genentech Says

Apr 16 2007

Accelerated “De-proval”? FDA May Be Ready To Withdraw Subpart H Drug

Aug 20 2007

With Avastin Approval For Breast Cancer, Will More Patients Hit Price Cap?

Mar 03 2008

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window